Skip to main content
logo
Dr. Reddy's Laboratories Limited (BOM:500124)
India flag India · Delayed Price · Currency is INR
1,147.60
+3.25 (0.28%)
At close: Jul 31, 2026

Dr. Reddy's Laboratories Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
33,10742,85056,54455,68445,06723,568
Depreciation & Amortization
21,21220,60517,05814,84112,63611,824
Loss (Gain) From Sale of Assets
-2,955-2,547-1,522-900208-1,119
Asset Writedown & Restructuring Costs
3,5343,5191,69336997,562
Loss (Gain) From Sale of Investments
-2,710-2,359-3,554-3,149-876-277
Loss (Gain) on Equity Investments
-140-134-217-147-370-703
Stock-Based Compensation
311326424407397592
Provision & Write-off of Bad Debts
55069016127520555
Other Operating Activities
3,7325,4415,830-1,3998,7645,104
Change in Accounts Receivable
-342-6,722-10,283-8,054-5,752-17,012
Change in Inventory
-9,711-8,601-12,753-18,445-2,654-9,912
Change in Accounts Payable
8712,7903403,460234,412
Change in Other Net Operating Assets
-6,260897-7,2932,8575284,014
Operating Cash Flow
41,19956,75546,42845,43358,87528,108
Operating Cash Flow Growth
-21.62%22.24%2.19%-22.83%109.46%-21.27%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-19,891-23,326-27,504-16,403-11,323-14,660
Sale of Property, Plant & Equipment
6333095121,06482370
Cash Acquisitions
-3,372-3,152-53,096---326
Sale (Purchase) of Intangibles
-8,573-13,698-6,162-11,011-7,543-1,443
Investment in Securities
-13,353-27,16724,801-15,716-23,366-11,201
Other Investing Activities
2,0661,5213,3721,783777873
Investing Cash Flow
-42,485-65,513-58,077-40,283-41,373-26,387

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-20,25724,4905,493-3,520
Long-Term Debt Issued
---3,800--
Total Debt Issued
20,18720,25724,4909,293-3,520
Short-Term Debt Repaid
-----19,382-
Long-Term Debt Repaid
--1,264-1,294-4,947-1,015-785
Total Debt Repaid
-6,759-1,264-1,294-4,947-20,397-785
Net Debt Issued (Repaid)
13,42818,99323,1964,346-20,3972,735
Issuance of Common Stock
449397193805368334
Repurchase of Common Stock
---1,389---
Common Dividends Paid
-6,659-6,659-6,662-6,648-4,979-4,146
Other Financing Activities
-4,842-4,4413,573-2,266-1,853-1,345
Financing Cash Flow
2,3768,29018,911-3,763-26,861-2,422

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
1,1051,243224-59286733
Net Cash Flow
2,1957757,4861,328-9,07332

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
21,30833,42918,92429,03047,55213,448
Free Cash Flow Growth
-8.57%76.65%-34.81%-38.95%253.60%-48.20%
Free Cash Flow Margin
6.43%9.95%5.81%10.40%19.34%6.27%
Free Cash Flow Per Share
25.5740.1222.6934.8357.1616.17
Levered Free Cash Flow
-3,9101,62811,28512,23129,6771,031
Unlevered Free Cash Flow
-1,3083,96413,05313,30130,5691,629

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
4,8424,4413,4832,2661,8531,345
Cash Income Tax Paid
12,28013,52619,99320,04710,7147,437
Change in Working Capital
-15,442-11,636-29,989-20,182-7,855-18,498